Nationwide’s chief market strategist Mark Hackett told CNBC’s Worldwide Exchange on Dec. 3 that survey data may look weak, but the underlying economy remains solid, creating a supportive backdrop for dip-buying and improving prospects for cyclicals and small caps.
Hackett said the ongoing divide between “soft” indicators, such as consumer sentiment and PMI surveys, and “hard” spending data has persisted since early 2025.
“There’s been a sharp disconnect between what people have been saying and what people have been doing,” he noted, adding that personal income, spending and PCE remain more reliable gauges of economic direction.
He described the recent government shutdown as producing an “echo” of the slowdown seen in April, when tariff uncertainty briefly paused hiring and survey activity. With official payroll data still catching up, he said the ADP report carries greater weight in the near term.
Despite market volatility, Hackett argued that investors have consistently bought pullbacks throughout the past several years, and that current fundamentals justify the behaviour.
“Technical indicators have rebounded, GDP is running roughly 3%–4%, and earnings growth is in the mid-teens,” he said.
While valuations remain stretched in mega-cap tech, he stressed that “the average company, the average small cap, the average value stock is actually quite reasonable today,” particularly as earnings growth broadens beyond the largest names in 2026.
Hackett identified cyclicals and small caps as his preferred segments, noting that both have lagged despite improving fundamentals. For the S&P 600 small-cap index, he pointed to expected high-teens earnings growth next year alongside valuations “well below average.”
-30
On Oct. 22, Paradigm Capital analyst Marvin Wolff raised his target on CHAR Technologies (CHAR Technologies Stock Quote, Chart, News,… [Read More]
Stifel analyst Justin Keywood maintained his “Buy” rating and $44.00 target on ATS Corporation (ATS Corporation Stock Quote, Chart, News,… [Read More]
Markets have been choppy, but billionaire investor Bill Ackman sees the potential for a much stronger backdrop in 2027. Speaking… [Read More]
Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and $1.00 target on Atlas Engineered Products (Atlas Engineered Products Stock… [Read More]
Roth Capital Partners analyst Boobalan Pachaiyappan initiated coverage of Atrium Therapeutics (Atrium Therapeutics, Stock Quote, Chart, News, Analysts, Financials NASDAQ:RNA)… [Read More]
Goodreid Investment Counsel president and CEO Gordon Reid says Texas Instruments (Texas Instruments Stock Quote, Chart, News, Analysts, Financials NASDAQ:TXN)… [Read More]